Skip to main content

Table 1 Baseline characteristics of the active and controlled groups

From: Effects and mechanism of moderate aerobic exercise on impaired fasting glucose improvement

Variables Active (n = 60) Controlled (n = 60)
Age (years) 42.4 ± 5.8 44.1 ± 6.6
Male, n (%) 33 (55.0) 35 (58.3)
BMI (kg/m2) 24.6 ± 3.3 24.8 ± 3.7
Overweight, n (%) 10 (16.7) 12 (20.0)
Obese, n (%) 9 (15.0) 8 (13.3)
Waist circumference (cm) 84.4 ± 7.6 82.9 ± 8.3
Smoking, n (%) 23 (38.3) 21 (35.0)
Hypertension, n (%) 16 (26.7) 18 (30.0)
Dyslipidemia, n (%) 19 (31.7) 18 (30.0)
SBP (mmHg) 127.8 ± 16.4 125.9 ± 15.7
DBP (mmHg) 79.8 ± 10.6 78.5 ± 11.7
HR (bpm) 73.7 ± 10.4 76.5 ± 9.9
TG (mmol/L) 1.8 ± 0.4 1.9 ± 0.3
TC (mmol/L) 5.7 ± 0.6 5.8 ± 0.5
LDL-C (mmol/L) 3.6 ± 0.3 3.7 ± 0.4
HDL-C (mmol/L) 1.1 ± 0.3 1.1 ± 0.2
Lp(a) (mg/L) 132.4 ± 15.6 135.7 ± 17.3
FBG (mmol/L) 6.3 ± 0.5 6.4 ± 0.4
HbA1c (%) 5.6 ± 0.4 5.6 ± 0.5
Cr (μmol/L) 98.7 ± 10.6 99.2 ± 9.9
BUN (mmol/L) 5.6 ± 1.3 5.9 ± 1.4
Hs-CRP (mg/L) 5.2 ± 1.1 5.6 ± 1.0
ROCK2 activity (mg/mL) 58.7 ± 6.0 60.2 ± 7.3
Fasting C-peptide level (nmol/L) 0.26 ± 0.05 0.28 ± 0.07
Fasting insulin level (pmol/L) 13.6 ± 2.2 14.1 ± 2.8
Daily average exercise time (min) 5.2 ± 3.8 5.9 ± 3.5
Aspirin, n (%) 28 (46.7) 26 (43.3)
ACEI, n (%) 9 (15.0) 7 (11.7)
ARB, n (%) 4 (6.7) 5 (8.3)
CCB, n (%) 4 (6.7) 3 (5.0)
Statins, n (%) 14 (23.3) 13 (21.7)
  1. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate (beat per minute), TG triglyceride, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, Lp(a) lipoprotein (a), FBG fasting blood glucose, Cr creatinine, BUN blood urea nitrogen, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker